title: Randomized trial of the efficacy of trimethoprim-sulfamethoxazole and prednisone in preventing post-tympanostomy tube morbidity.
abstract: This study was designed to determine whether treatment with prednisone and trimethoprim-sulfamethoxazole would reduce first year post-operative morbidity in children with chronic otitis media with effusion undergoing tympanostomy tube insertion (intubation). Eighty children ages 6 months to 8 years were enrolled at intubation and randomized from age strata to receive active drugs or placebos for 14 days after surgery. They were examined with pneumatic otoscopy and tympanometry preoperatively and at 3 weeks and 3, 6, 9 and 12 months after surgery. Active drug treatment significantly reduced tube obstruction or extrusion in the first 3 postoperative months compared with placebos (4% vs. 17%, P = .01). However, rates of repeat intubation, otorrhea and recurrence of otitis media did not differ significantly in the two groups. Children with chronic otitis media with effusion treated with intubation may benefit from a 2-week course of prednisone and trimethoprim-sulfamethoxazole at the time of surgery. However, there is no apparent long term benefit of this treatment.
authors: Otitis Media Research Center, Minneapolis, MN 55455, USA.
authors: K A
authors: KA
authors: Daly
authors: G S
authors: GS
authors: Giebink
authors: B
authors: B
authors: Lindgren
authors: R H
authors: RH
authors: Margolis
authors: D
authors: D
authors: Westover
authors: L L
authors: LL
authors: Hunter
authors: C T
authors: CT
authors: Le
authors: D
authors: D
authors: Buran
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008876:Middle Ear Ventilation; D008910:Minnesota / Q000453:epidemiology; D009017:Morbidity; D010034:Otitis Media with Effusion / Q000453:epidemiology / Q000628:therapy*; D011183:Postoperative Complications / Q000517:prevention & control*; D011241:Prednisone / Q000627:therapeutic use*; D012008:Recurrence; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
chemical_list: D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011241:Prednisone